Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,575.00 at Barclays

Mettler-Toledo International (NYSE:MTD) had its price target upped by research analysts at Barclays from $1,300.00 to $1,575.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective points to a potential upside of 11.03% from the stock’s previous close.

MTD has been the topic of a number of other research reports. Jefferies Financial Group boosted their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research note on Friday. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. JPMorgan Chase & Co. decreased their price objective on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Weiss Ratings cut shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 21st. Finally, Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $1,445.36.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,418.55 on Monday. Mettler-Toledo International has a 1-year low of $1,023.05 and a 1-year high of $1,525.17. The firm’s 50-day moving average price is $1,237.30 and its two-hundred day moving average price is $1,274.51. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 159.45. The stock has a market capitalization of $28.67 billion, a price-to-earnings ratio of 31.93, a P/E/G ratio of 2.92 and a beta of 1.23.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 EPS for the quarter, topping the consensus estimate of $10.80 by $0.66. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.Mettler-Toledo International’s revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $10.09 EPS. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. On average, equities analysts predict that Mettler-Toledo International will post 47.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of MTD. Evergreen Capital Management LLC raised its stake in shares of Mettler-Toledo International by 4.5% during the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock worth $257,000 after buying an additional 8 shares during the last quarter. Meridian Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 1.7% in the 4th quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock valued at $680,000 after purchasing an additional 8 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of Mettler-Toledo International by 2.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 302 shares of the medical instruments supplier’s stock valued at $421,000 after purchasing an additional 8 shares during the period. Values First Advisors Inc. boosted its position in shares of Mettler-Toledo International by 1.3% in the 1st quarter. Values First Advisors Inc. now owns 625 shares of the medical instruments supplier’s stock worth $789,000 after purchasing an additional 8 shares during the last quarter. Finally, Torray Investment Partners LLC boosted its position in shares of Mettler-Toledo International by 0.5% in the 1st quarter. Torray Investment Partners LLC now owns 1,677 shares of the medical instruments supplier’s stock worth $2,115,000 after purchasing an additional 8 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.